Abstract
摘要
相似文献
1
Methylphenidate.
J Sch Nurs. 1996 Feb;12(1):5-8, 10-1.
2
[Methylphenidate. A possibility for rare hyperactive children].
Rev Infirm. 2004 Sep(103):39-40.
3
Transdermal methylphenidate (Daytrana) for ADHD.
Med Lett Drugs Ther. 2006 Jun 19;48(1237):49-51.
4
[Methylphenidate (Ritalin) treatment in attention deficit hyperactivity disorder].
Harefuah. 1997 May 1;132(9):672-5.
5
6
Comments on efficacy and tolerability of OROS methylphenidate in Korean children with attention-deficit/hyperactivity disorder.
Prog Neuropsychopharmacol Biol Psychiatry. 2007 Jun 30;31(5):1149-50; author reply 1151-2. doi: 10.1016/j.pnpbp.2007.03.018. Epub 2007 Apr 1.
7
[Attention deficit disorder with hyperactivity (ADHD). Continuing symptom control with medium term methylphenidate treatment].
Med Monatsschr Pharm. 2006 Nov;29(11):415-6.
8
Attention-deficit hyperactivity disorder, methylphenidate, and primary encopresis.
Psychosomatics. 2009 Mar-Apr;50(2):178. doi: 10.1176/appi.psy.50.2.178.
9
Attention deficit hyperactivity disorder, chronic tic disorder, and methylphenidate.
Adv Neurol. 2006;99:197-207.
10
Hematologic and blood biochemistry monitoring during methylphenidate treatment in children with attention-deficit/hyperactivity disorder: 2-year, open-label study results.
Pediatrics. 2007 Jul;120(1):e120-8. doi: 10.1542/peds.2006-1402. Epub 2007 Jun 4.
引用本文的文献
1
Long-term behavioral effects in a rat model of prolonged postnatal morphine exposure.
Behav Neurosci. 2015 Oct;129(5):643-55. doi: 10.1037/bne0000081. Epub 2015 Jul 27.
Zotero 插件